Literature DB >> 22365628

Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors.

Chin Loon Ong1, Wilko F A R Verbakel, Max Dahele, Johan P Cuijpers, Ben J Slotman, Suresh Senan.   

Abstract

PURPOSE: Flattening filter-free (FFF) beams with higher dose rates and faster delivery are now clinically available. The purpose of this planning study was to compare optimized non-FFF and FFF RapidArc plans for stereotactic body radiotherapy (SBRT) and to validate the accuracy of fast arc delivery. METHODS AND MATERIAL: Ten patients with peripheral lung tumors and 10 with vertebral metastases were planned using RapidArc with a flattened 6-MV photon beam and a 10-MV FFF beam for fraction doses of 7.5-18 Gy. Dosimetry of the target and organs at risk (OAR), number of monitor units (MU), and beam delivery times were assessed. GafChromic EBT2 film measurements of FFF plans were performed to compare calculated and delivered dose distributions.
RESULTS: No major dosimetric differences were seen between the two delivery techniques. For lung SBRT plans, conformity indices and OAR doses were similar, although the average MU required were higher with FFF plans. For vertebral SBRT, FFF plans provided comparable PTV coverage, with no significant differences in OAR doses. Average beam delivery times were reduced by a factor of up to 2.5, with all FFF fractions deliverable within 4 min. Measured FFF plans showed high agreement with calculated plans, with more than 99% of the area within the region of interest fulfilling the acceptance criterion.
CONCLUSION: The higher dose rate of FFF RapidArc reduces delivery times significantly, without compromising plan quality or accuracy of dose delivery.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365628     DOI: 10.1016/j.ijrobp.2011.12.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.

Authors:  Matthew M Gestaut; Nitika Thawani; Sangroh Kim; Veera R Gutti; Sameer Jhavar; Niloyjyoti Deb; Andrew Morrow; Russell A Ward; Jason H Huang; Mehul Patel
Journal:  J Neurooncol       Date:  2017-04-13       Impact factor: 4.130

2.  Comparison of deliverable IMRT and VMAT for spine metastases using a simultaneous integrated boost.

Authors:  Y K Lee; J L Bedford; H A McNair; M A Hawkins
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

3.  Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.

Authors:  J-Y Lu; Z Lin; P-X Lin; B-T Huang
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

4.  Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Authors:  Marta Scorsetti; Piera Navarria; Fiorenza De Rose; AnnaMaria Ascolese; Elena Clerici; Ciro Franzese; Francesca Lobefalo; Giacomo Reggiori; Pietro Mancosu; Stefano Tomatis; Antonella Fogliata; Luca Cozzi
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-17       Impact factor: 4.553

5.  Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams.

Authors:  Bao-Tian Huang; Jia-Yang Lu; Pei-Xian Lin; Jian-Zhou Chen; Yu Kuang; Chuang-Zhen Chen
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  Dose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy treatment with flattening filter free beams and the potential role of calculation grid size.

Authors:  Baotian Huang; Lili Wu; Peixian Lin; Chuangzhen Chen
Journal:  Radiat Oncol       Date:  2015-02-26       Impact factor: 3.481

7.  Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution.

Authors:  Juliane Rieber; Eric Tonndorf-Martini; Oliver Schramm; Bernhard Rhein; Laila König; Sebastian Adeberg; Eva Meyerhof; Angela Mohr; Jutta Kappes; Hans Hoffmann; Jürgen Debus; Stefan Rieken
Journal:  Radiat Oncol       Date:  2016-06-08       Impact factor: 3.481

Review 8.  A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer?

Authors:  Daniel Sapkaroski; Catherine Osborne; Kellie A Knight
Journal:  J Med Radiat Sci       Date:  2015-05-25

9.  On the robustness of VMAT-SABR treatment plans against isocentre positioning uncertainties.

Authors:  Joep Stroom; Sandra Vieira; Dalila Mateus; Carlo Greco; Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2014-09-05       Impact factor: 3.481

10.  Dose calculation for hypofractionated volumetric-modulated arc therapy: approximating continuous arc delivery and tongue-and-groove modeling.

Authors:  Jie Yang; Grace Tang; Pengpeng Zhang; Margie Hunt; Seng B Lim; Thomas LoSasso; Gig Mageras
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.